Growth Metrics

Conmed (CNMD) Capital Expenditures Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -17.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 34.96%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -6.72%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -5.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 15.89%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -47.73%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -11.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -43.42%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 27.22%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn -23.47%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -23.47%
Dec 31, 2025 26.51%
Sep 30, 2025 51.71%
Jun 30, 2025 59.58%
Mar 31, 2025 85.70%
Dec 31, 2024 -16.79%
Sep 30, 2024 -36.61%
Jun 30, 2024 -20.73%
Mar 31, 2024 -52.16%
Dec 31, 2023 -14.46%
Sep 30, 2023 -19.62%
Jun 30, 2023 -20.70%
Mar 31, 2023 15.38%
Dec 31, 2022 78.04%
Sep 30, 2022 20.38%
Jun 30, 2022 90.75%
Mar 31, 2022 18.59%
Dec 31, 2021 1.24%
Sep 30, 2021 69.61%
Jun 30, 2021 -20.20%
Mar 31, 2021 10.05%
Dec 31, 2020 -49.14%
Sep 30, 2020 -32.49%
Jun 30, 2020 -24.72%
Mar 31, 2020 -29.76%
Dec 31, 2019 30.17%
Sep 30, 2019 9.17%
Jun 30, 2019 42.08%
Mar 31, 2019 6.32%
Dec 31, 2018 31.75%
Sep 30, 2018 20.31%
Jun 30, 2018 19.28%
Mar 31, 2018 46.40%
Dec 31, 2017 -16.38%
Sep 30, 2017 33.88%
Jun 30, 2017 -39.71%
Mar 31, 2017 -7.35%
Dec 31, 2016 22.26%
Sep 30, 2016 -25.06%
Jun 30, 2016 31.06%
Mar 31, 2016 -31.32%
Dec 31, 2015 11.71%
Sep 30, 2015 2.38%
Jun 30, 2015 -18.66%
Mar 31, 2015 -0.10%
Dec 31, 2014 -35.40%
Sep 30, 2014 -32.55%
Jun 30, 2014 12.40%
Mar 31, 2014 -1.57%
Dec 31, 2013 -12.04%
Sep 30, 2013 22.36%
Jun 30, 2013 -21.29%
Mar 31, 2013 -35.71%
Dec 31, 2012 14.00%
Sep 30, 2012 6.76%
Jun 30, 2012 16.67%
Mar 31, 2012 55.06%
Dec 31, 2011 25.87%
Sep 30, 2011 -77.27%